Clarity Medical Systems, Inc. Announces Significant Update to HOLOS IntraOp™ System
HOLOS Update Includes New IOL Predictor Formula, Physician Portal; To Be Showcased At ASCRS 2016 Pleasanton, CA – [May 6, 2016] – Clarity Medical Systems, Inc., a medical device company focused on the manufacture of integrated optical systems for the diagnosis and management of eye disorders, announces the pending release of the HOLOS Barrett Intraocular Lens Formula™, which will be available exclusively on the HOLOS IntraOp™ Wavefront Aberrometer mid-year. Developed by Graham Barrett, MD; Douglas D. Koch, MD; and Warren Hill, MD, the new IOL predictor formula incorporates elements from validated formulae used to calculate IOL power and adds aphakic data taken at the time of surgery to provide additional accuracy of a patient’s refractive needs. Clarity will unveil the HOLOS Barrett IOL Formula and additional product updates to HOLOS at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) meeting, being held May 6 to 10 in New Orleans, Louisiana at Booth #2537. The HOLOS Barrett IOL Formula will be released as part of a comprehensive software update that will also include enhancements to the graphical user interface, as well as other functionalities of the system. “The HOLOS Barrett IOL Formula is the result of industry-leading research and development which provides anterior segment surgeons a valuable resource to assist physicians in achieving their desired refractive outcome with precision,” said Barry J. Linder, MD and Clarity Medical’s Chief Medical Officer. “The HOLOS IntraOp™ Wavefront Aberrometer is specifically designed for cataract surgery and supplies real-time, dynamic aphakic measurements during cataract surgery. Adding this data to proven and validated formulae will increase confidence in a physician’s ability to reach the refractive target consistently and accurately.” The HOLOS Barrett IOL Formula is based on the Barrett Universal II and Barrett Rx formulae. The rigorously tested and widely used Barrett Universal II formula provides surgeons a recommended IOL power for desired spherical equivalent refraction using preoperative biometry measurements. The Barrett Rx formula incorporates data from the Barrett II, as well as the calculated effective lens position and refractive outcome to provide IOL power for postoperative corrections, including piggy back IOL, lens exchange, and determining the optimum angle to rotate a toric IOL to minimize astigmatism. The addition of aphakic measurements acquired using the HOLOS IntraOp™ Wavefront Aberrometer provides unique data to further refine IOL power calculation with the existing formulae. Clarity Medical ASCRS Onsite Activities Educational Session Saturday, May 7, 8:00am – 9:30am Central Time Ernest N. Morial Convention Center, Room 252 Intraoperative Aberrometry: Giving Insight Into Your Surgery
  • Moderator:
    • Robert Osher, MD
  • Faculty:
    • Kerry Assil, MD
    • William Christian, MD
    • Keith Liang, MD
    • Jay Lippman, MD
    • Jonathan Solomon, MD
  About HOLOS Wavefront Aberrometry HOLOS Wavefront Aberrometry provides cataract surgeons critical surgical information in real time, generating clear, continuous refractive data and assisting in the insertion and rotation of IOLs, titration of limbal relaxing incisions and opening of arcuate incisions. The system displays detailed refractive data as it changes during the phakic, aphakic, and pseudophakic phases of procedures, helping surgeons proceed with confidence at all stages of cataract removal and lens insertion. About Clarity Medical Systems, Inc. Clarity Medical Systems, Inc., develops, manufactures and markets advanced newborn and pediatric ophthalmic imaging systems, guidance and informatics tools that enhance the clinician’s ability to diagnose, manage, and treat eye disorders. Clarity’s HOLOS IntraOp™, is a continuous real-time intraoperative aberrometer for refractive cataract surgery. HOLOS IntraOp™ is designed to provide real-time, intraoperative refractive guidance and data throughout all phases of surgery to assist physicians in better achievement of their patients’ refractive goals. The company’s RetCam™ product line is helping to improve the quality of eye healthcare in the pediatric populations worldwide and is sold to leading Neonatal Intensive Care Units on a global basis. To date, over 1,800 RetCam systems have been installed and the eyes of more than one million children have been imaged in over 85 countries. (www.claritymsi.com)

May, 2016